BIOLASE Inc (BIOL.OQ)
23 Jul 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|62||2017||Chairman of the Board|
|54||2018||Interim Chief Executive Officer, Chief Financial Officer|
|38||2015||Vice President - Finance and Corporate Controller|
|54||2016||Vice President, Managing Director of Europe, the Middle East and Africa|
|2017||Vice President - Sales, Americas|
- BRIEF-Biolase Announces 1-For-5 Reverse Stock Split Common Stock Will Begin Trading On Split-Adjusted Basis On May 11
- BRIEF-Biolase Has Asked Jonathan Lord Chairman Of Board Of Biolase, To Lead Co's Exploration Of Strategic Alternatives
- BRIEF-Biolase Names Garrett Sato To Board Of Directors
- BRIEF-Biolase Reports Q4 Loss Per Share $0.05
- BRIEF-BIOLASE Secures $6 Mln Revolving Line Of Credit